Akebia Therapeutics | AKBA - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
Akebia Therapeutics 167 37 2023-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
Amgen 28K 1.3K 2024-12
Ardelyx 395 128 2024-12
Astellas Pharma 13.64K 1.11K 2025-12
AstraZeneca USD 89.9K 6.4K 2023-12
Bayer 99.72K 1.65K 2023-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Celltrion 1.07K 94 2015-12
Cspc Pharmaceutical CNY 23.5K 1.34K 2023-12
Dianthus Therapeutics 53 14 2023-12
Exelixis 1.15K 163 2025-12
Fresenius Medical Care 112.38K 7.83K 2023-12
GlaxoSmithKline 69.4K 20.7K 2022-12
Ionis Pharmaceuticals 1.07K 142 2024-12
Ironwood Pharmaceuticals 267 48 2023-12
J&J 138.1K 6.2K 2024-12
Kangmei Pharma 6.37K 39 2022-12
Karyopharm Therapeutics 325 60 2023-12
Knight Therapeutics 698 38 2022-12
Laboratorios Farma 1.99K 242 2022-12
Lexicon Pharmaceuticals 285 150 2023-12
Malin Corporation 5 1 2022-12
Moderna 5.8K 200 2024-12
Nektar Therapeutics 137 79 2023-12
Organigram Holdings 1.14K 241 2025-12
Prothena 163 10 2024-12
PTC Therapeutics 939 49 2024-12
Qiagen NV USD 6.18K 150 2022-12
Regeneron Pharmaceuticals 13.45K 1.6K 2023-12
Roche Holding 103.61K 2.69K 2022-12
Sanofi 84.59K 3.41K 2024-12
Sarepta Therapeutics 1.37K 58 2024-12
Sartorius 15.94K 2.11K 2022-12
Sino Biopharmaceutical CNY 25.81K 466 2023-12
Tectonic Therapeutic 45 1 2023-12
Tilray USD 2.84K 192 2025-12
Vanda Pharmaceuticals 203 87 2023-12
Zz Pientze Pharmaceu 2.72K 129 2022-12